CinCor Pharma Inc (CINC)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | 2022-11-28 | V Vente | Administrateur non-exécutif Actionnaire important |
6 000
-100.0%
14,3285 920 USD |
6 000 -100.0% | 14,32 | 85 920 USD | |
| 2022-08-17 | 2022-08-15 | A Achat | Actionnaire important |
487 333
+inf%
30,0014 619 990 USD |
487 333 +inf% | 30,00 | 14 619 990 USD | |
| 2022-08-17 | 2022-08-15 | A Achat | Actionnaire important |
112 667
+2.9%
30,003 380 010 USD |
112 667 +2.9% | 30,00 | 3 380 010 USD | |
| 2022-08-17 | 2022-08-15 | A Achat | Actionnaire important |
133 333
+3.3%
30,003 999 990 USD |
133 333 +3.3% | 30,00 | 3 999 990 USD | |
| 2022-08-15 | 2022-08-11 | A Achat |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Actionnaire important |
83 000
+2.0%
30,002 490 000 USD |
83 000 +2.0% | 30,00 | 2 490 000 USD | |
| 2022-08-15 | 2022-08-11 | A Achat |
Sofinnova Venture Partners X, L.P. Actionnaire important |
500 000
+9.0%
30,0015 000 000 USD |
500 000 +9.0% | 30,00 | 15 000 000 USD | |
| 2022-08-15 | 2022-08-11 | A Achat | Actionnaire important |
83 000
+2.0%
30,002 490 000 USD |
83 000 +2.0% | 30,00 | 2 490 000 USD | |
| 2022-08-15 | 2022-08-11 | A Achat | Administrateur non-exécutif Actionnaire important |
6 000
+inf%
30,00180 000 USD |
6 000 +inf% | 30,00 | 180 000 USD | |
| 2022-08-15 | 2022-08-11 | A Achat | Administrateur non-exécutif Actionnaire important |
500 000
+9.0%
30,0015 000 000 USD |
500 000 +9.0% | 30,00 | 15 000 000 USD | |
| 2023-02-27 | 2022-06-10 | V Vente |
Chief Medical Officer Dirigeant |
6
-0.2%
15,2191 USD |
6 -0.2% | 15,21 | 91 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
EVP CFO & Chief BD Officer Dirigeant |
100
+inf%
16,001 600 USD |
100 +inf% | 16,00 | 1 600 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
Sofinnova Venture Partners X, L.P. Actionnaire important |
325 000
+6.2%
16,005 200 000 USD |
325 000 +6.2% | 16,00 | 5 200 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat | Administrateur non-exécutif Actionnaire important |
325 000
+6.2%
16,005 200 000 USD |
325 000 +6.2% | 16,00 | 5 200 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat | Actionnaire important |
220 000
+5.7%
16,003 520 000 USD |
220 000 +5.7% | 16,00 | 3 520 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat | Actionnaire important |
312 500
+170.0%
16,005 000 000 USD |
312 500 +170.0% | 16,00 | 5 000 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat | Actionnaire important |
157 500
+4.3%
16,002 520 000 USD |
157 500 +4.3% | 16,00 | 2 520 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Actionnaire important |
1 700 000
+70.1%
16,0027 200 000 USD |
1 700 000 +70.1% | 16,00 | 27 200 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
Chief Executive Officer Administrateur exécutif |
12 500
+inf%
16,00200 000 USD |
12 500 +inf% | 16,00 | 200 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
Chief Operating Officer Dirigeant |
1 500
+inf%
16,0024 000 USD |
1 500 +inf% | 16,00 | 24 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
Chief Operating Officer Dirigeant |
750
+0.6%
16,0012 000 USD |
750 +0.6% | 16,00 | 12 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
EVP Clinical Development Dirigeant |
100
+inf%
16,001 600 USD |
100 +inf% | 16,00 | 1 600 USD | |
| 2022-01-13 | 2022-01-11 | A Achat |
EVP Clinical Development Dirigeant |
2 500
+inf%
16,0040 000 USD |
2 500 +inf% | 16,00 | 40 000 USD | |
| 2022-01-13 | 2022-01-11 | A Achat | Actionnaire important |
1 700 000
+70.1%
16,0027 200 000 USD |
1 700 000 +70.1% | 16,00 | 27 200 000 USD |